Latest Schedule 13D activist filings

Avinoam Eizenman, Executive Chairman of Silicom Ltd., has disclosed beneficial ownership of 327,559 ordinary shares, representing 5.70% of the outstanding shares, with additional equity awards set to vest soon.

The Woodbridge Company Limited and affiliated entities filed an amendment to their Schedule 13D, confirming their ongoing controlling interest in Thomson Reuters Corporation.

Material Impact Partners II and associated entities disclose a 25.2% beneficial ownership in Nauticus Robotics following an increase in the company's total outstanding shares.

Peter Puccetti has sold his interest in Goodwood Inc., significantly reducing his beneficial ownership in Cosciens Biopharma to 0.5%.

Christian Glibert reports a reduction in beneficial ownership of ENvue Medical to 6.5% due to share issuance.

RA Capital Management reports a 17.1% stake in Wave Life Sciences as the company initiates a redomiciliation to Delaware via a Scheme of Arrangement.

Fluor Corporation and its subsidiary have reduced their beneficial ownership in NuScale Power Corp. to 3.9%, triggering the final amendment to their Schedule 13D filing.

Fluor Corporation and its subsidiary have reduced their beneficial ownership in NuScale Power Corp. to 3.9%, triggering the final amendment to their Schedule 13D filing.

Millstreet Capital Management reports a reduction in its beneficial ownership of Diebold Nixdorf common shares.

Reporting person Ting Chuan Lee has increased their beneficial ownership in Ainos, Inc. to 10.98% following a grant of 570,000 restricted stock units.

Chun-Jung Tsai filed an amendment to Schedule 13D reporting beneficial ownership of 686,999 shares of Ainos, Inc. common stock.

Ainos Inc. filed an amendment to its Schedule 13D disclosing changes in beneficial ownership following the vesting of restricted stock units.

The reporting group, including the estate of Carl DeSantis, has ceased beneficial ownership of Integrated BioPharma, Inc. shares.

Sherborne Investors reports a change in beneficial ownership percentage due to a reduction in Navient's outstanding shares and confirms the appointment of Edward Bramson as CEO.

Carl C. Icahn and affiliated entities increased their beneficial ownership of Icahn Enterprises L.P. to 86.89% following a quarterly distribution of depositary units.

Damon DeSantis and CDDS 2.0, LLC have reported a combined 41.3% beneficial ownership stake in Integrated Biopharma, Inc. following a series of internal share transfers.

JCP Investment Management has filed a Schedule 13D reporting a 5.1% beneficial ownership stake in Barnwell Industries, Inc.

Forager Capital Management has submitted a non-binding proposal to acquire all outstanding shares of Repay Holdings Corp for $4.80 per share in cash.

Chairman and CEO T. Benjamin Jennings transferred 4.1 million shares of Panamera Holdings as a personal gift.

Allan S. Martin and associated entities disclosed a reduction in their beneficial ownership of Oxbridge Re Holdings Ltd ordinary shares.

CEO Jack Kaye and his controlled entities have disclosed a 42% beneficial ownership stake in Davion Healthcare PLC.

British American Tobacco has expanded its investment in Organigram Global Inc. following the acquisition of Sanity Group GmbH and a concurrent private placement.

TCW Group, Inc. has increased its beneficial ownership in Accuray Inc. to 11.5% through the issuance of new common stock purchase warrants.

Sylebra Capital has filed an amendment to its Schedule 13D, reporting a reduction in its beneficial ownership of 8x8, Inc. common stock to 4.85%.

Rakuten Mobile has entered into a trading plan to sell up to 15.5 million shares of AST SpaceMobile, representing approximately 5.3% of the outstanding Class A Common Stock.

Joseph Lubin and affiliated entities filed an amended Schedule 13D to reflect estate planning transfers and the exercise of pre-funded warrants in Sharplink, Inc.

Two Seas Capital LP has reported a 5.7% beneficial ownership stake in Core Scientific, Inc. through a Schedule 13D filing.

CEO Yue Zhu has rescinded a previous acting-in-concert agreement and acquired 2 million additional Class B shares to consolidate voting control.

Voss Capital has entered into a board observer agreement with PAR Technology Corp, granting Jon Hook a non-voting observer role for one year.

Investor Velibor Krstic has increased his stake in Strata Critical Medical warrants to 16.21% and is calling for a mandatory exchange to prevent expiration.